Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CCLD Stock Forecast 2025-2026
$2.36
Current Price
$104.11M
Market Cap
Buy 1
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to CCLD Price Targets
+154.2%
To High Target of $6.00
+111.9%
To Median Target of $5.00
-4.7%
To Low Target of $2.25
CCLD Price Momentum
+4.0%
1 Week Change
+8.3%
1 Month Change
+16.8%
1 Year Change
-35.5%
Year-to-Date Change
-51.2%
From 52W High of $4.84
+106.7%
From 52W Low of $1.14
📊 TOP ANALYST CALLS
Did CCLD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if CareCloud is one of their latest high-conviction picks.
Latest CCLD Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, CCLD has a neutral consensus with a median price target of $5.00 (ranging from $2.25 to $6.00). Currently trading at $2.36, the median forecast implies a 111.9% upside. This outlook is supported by 1 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CCLD Analyst Ratings
1
Buy
1
Hold
0
Sell
CCLD Price Target Range
Low
$2.25
Average
$5.00
High
$6.00
Current: $2.36
Latest CCLD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CCLD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 14, 2025 | Roth MKM | Richard Baldry | Neutral | Reiterates | $1.50 |
| Nov 15, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $4.50 |
| Aug 27, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $4.50 |
| May 16, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $4.00 |
| Mar 25, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $3.50 |
| Mar 22, 2024 | Maxim Group | Allen Klee | Buy | Upgrade | $3.00 |
| Nov 16, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $3.50 |
| Aug 4, 2023 | Roth MKM | Richard Baldry | Neutral | Downgrade | $3.00 |
| May 5, 2023 | EF Hutton | Constantine Davides | Buy | Reiterates | $8.50 |
| Mar 20, 2023 | EF Hutton | Constantine Davides | Buy | Initiates | $8.50 |
| Mar 3, 2023 | HC Wainwright & Co. | Kevin Dede | Buy | Reiterates | $5.00 |
| Dec 13, 2022 | Maxim Group | Buy | Maintains | $0.00 | |
| Mar 15, 2022 | B. Riley Securities | Buy | Maintains | $0.00 | |
| Jun 11, 2021 | Cantor Fitzgerald | Overweight | Initiates | $0.00 |
CareCloud Inc. (CCLD) Competitors
The following stocks are similar to CareCloud based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CareCloud Inc. (CCLD) Financial Data
CareCloud Inc. has a market capitalization of $104.11M with a P/E ratio of -8.4x. The company generates $112.51M in trailing twelve-month revenue with a 8.9% profit margin.
Revenue growth is +6.4% quarter-over-quarter, while maintaining an operating margin of +7.7% and return on equity of +21.0%.
Valuation Metrics
Market Cap
$104.11M
Enterprise Value
$96.36M
P/E Ratio
-8.4x
PEG Ratio
-4.6x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
+6.4%
Gross Margin
+44.0%
Operating Margin
+7.7%
Net Margin
+8.9%
EPS Growth
+6.4%
Financial Health
Cash/Price Ratio
+6.8%
Current Ratio
1.7x
Debt/Equity
6.1x
ROE
+21.0%
ROA
+9.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
CareCloud Inc. (CCLD) Business Model
About CareCloud Inc.
What They Do
Provides cloud-based healthcare technology solutions.
Business Model
CareCloud Inc. generates revenue by offering cloud-based solutions for practice management, electronic health records, and revenue cycle management tailored to healthcare providers. The company's integrated platform enhances operational efficiency and clinical workflows for medical practices, enabling them to improve patient outcomes and financial performance.
Additional Information
CareCloud serves a diverse range of clients, including ambulatory practices, physician groups, and billing companies, positioning itself as a key player in the rapidly evolving healthcare IT sector. The ongoing demand for digital solutions in healthcare suggests a robust growth potential as providers adapt to regulatory changes and rising patient expectations.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
3,650
CEO
Mr. A. Hadi Chaudhry
Country
United States
IPO Year
2023
Website
www.carecloud.comCareCloud Inc. (CCLD) Latest News & Analysis
Latest News
Quick Summary
CareCloud, Inc. (Nasdaq: CCLD) surpassed the accelerated filer threshold with an $85.1 million public float, triggering new SEC compliance requirements for internal control audits.
Why It Matters
CareCloud's surpassing of the accelerated filer threshold indicates increased scrutiny and regulatory compliance, potentially impacting its operational costs and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CareCloud, Inc. (Nasdaq: CCLD, CCLDO) announced that its accounting firm may resign if required to attest to the company's Internal Control over Financial Reporting for fiscal year 2025.
Why It Matters
CareCloud's potential accounting firm resignation raises concerns about its financial reporting integrity and compliance, impacting investor confidence and stock stability.
Source: GlobeNewsWire
Market Sentiment:
Neutral
CareCloud to Present on AI Innovation at Maxim Group's 2025 Virtual Tech Conference on June 3, 2025
1 month ago
Quick Summary
CareCloud, Inc. (Nasdaq: CCLD, CCLDO) will participate in the "2025 Virtual Tech Conference" on June 3, 2025, featuring its Co-CEOs in a Healthcare IT panel.
Why It Matters
CareCloud's participation in a prominent tech conference highlights its leadership in AI healthcare solutions, potentially boosting investor confidence and influencing stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Shareholders re-elected three board members, approved executive compensation, and appointed a public accounting firm.
Why It Matters
Re-election of board members and approval of executive compensation signal stability and confidence in leadership, while appointing an accounting firm ensures financial oversight, impacting investor trust.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CareCloud, Inc. (Nasdaq: CCLD, CCLDO) has been named Maxim Group's "Top Healthcare IT Pick for 2025" due to its AI strategy, strong financials, and increased M&A activity.
Why It Matters
Maxim Group's endorsement of CareCloud as a top pick highlights its strong financials and AI strategy, signaling potential growth and investment interest in the healthcare tech sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CareCloud, Inc. (NASDAQ:CCLD) will hold its Q1 2025 Earnings Conference Call on May 6, 2025, at 8:30 AM ET, featuring company executives and analysts from Maxim Group and Zacks.
Why It Matters
CareCloud's Q1 2025 earnings call signals upcoming financial performance insights, crucial for assessing company growth and investment potential in the healthcare tech sector.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About CCLD Stock
What is CareCloud Inc.'s (CCLD) stock forecast for 2026?
Based on our analysis of 6 Wall Street analysts, CareCloud Inc. (CCLD) has a median price target of $5.00. The highest price target is $6.00 and the lowest is $2.25.
Is CCLD stock a good investment in 2026?
According to current analyst ratings, CCLD has 1 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.36. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CCLD stock?
Wall Street analysts predict CCLD stock could reach $5.00 in the next 12 months. This represents a 111.9% increase from the current price of $2.36. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is CareCloud Inc.'s business model?
CareCloud Inc. generates revenue by offering cloud-based solutions for practice management, electronic health records, and revenue cycle management tailored to healthcare providers. The company's integrated platform enhances operational efficiency and clinical workflows for medical practices, enabling them to improve patient outcomes and financial performance.
What is the highest forecasted price for CCLD CareCloud Inc.?
The highest price target for CCLD is $6.00 from at , which represents a 154.2% increase from the current price of $2.36.
What is the lowest forecasted price for CCLD CareCloud Inc.?
The lowest price target for CCLD is $2.25 from at , which represents a -4.7% decrease from the current price of $2.36.
What is the overall CCLD consensus from analysts for CareCloud Inc.?
The overall analyst consensus for CCLD is neutral. Out of 6 Wall Street analysts, 1 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $5.00.
How accurate are CCLD stock price projections?
Stock price projections, including those for CareCloud Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 8, 2025 3:54 AM UTC